Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
Dear colleagues,
 
The Belgian Early Warning System Drugs (BEWSD) at the Scientific Institute of Public Health (WIV-ISP) was informed of the analysis of two ecstasy tablets containing a high amount of MDMA.
These tablets were analysed in the framework of the Modus Fiesta drug testing service in Brussels.
 
The tablet characteristics can be found in the table below, together with pictures of the tablets.

 
 
The BEWSD would like to draw your attention to these tablets, and would like to remind you that the majority of ecstasy tablets currently circulating are highly dosed, sometimes containing dosages of up to 300 mg MDMA base.
The amount of MDMA present in an ecstasy tablet can only be determined using laboratory analysis.
 
Symptoms of an MDMA overdose are characterised by heavy sweating, tremor, dry mouth, nausea, vomiting, elevated blood pressure and heart rate, paranoia and hyperthermia.
In severe cases a serotonin syndrome can occur, resulting in an often fatal hyperthermia.
 
Please inform your networks, and don’t hesitate to contact us if you receive signals about similar tablets.
 
Kind regards,
 
Peter
 
Dr. Apr. Peter Blanckaert
Coordinator Belgian Early Warning System on Drugs
DO Public Health&Surveillance, Drugs Program (BMCDDA)
Juliette Wytsmanstraat 14 | 1050 Brussels
T + 32 2 642 54 08 | F + 32 2 642 54 10 | GSM Wacht +32 475 84 68 16
Skype: wiv-isp.peter.blanckaert
 
Institut Scientifique de Santé Publique
Wetenschappelijk Instituut Volksgezondheid
Scientific Institute of Public Health
www.wiv-isp.be
 
DISCLAIMER
The information in this message is exclusively meant for the EWS-network, and was sent to you, as a member of this network, in a confidential way.
Therefore the information in this message may not be copied, transferred or made public without the prior permission of the WIV-ISP.
The WIV-ISP takes responsibility for the editing of a press release, if considered as necessary in the framework of its mission.
The information contained in this document is also available on the BEWSD-website (with corresponding pdf-files and analytical data).
This part of the website is not accessible for the general public. A login can be requested by contacting ews.drugs@wiv-isp.be.
 
BEWSD ALERT LEVELS
The BEWSD has decided to distinguish its alert messages depending on the severity of the reported information.
The following 4 alert levels are used, and will always be indicated between brackets ([]) in the subject line of the alert message.